Published on September 4, 2009 at 4:16 AM
Reportlinker.com announces that a new market research report is available in its catalogue.Therapeutics for Memory and Cognition Disorders
http://www.reportlinker.com/p0118583/Therapeutics-for-Memory-and-Cognition-Disorders.html
This Report:
Details the disease states that lead to memory & cognition impairment
Provides forecasts and detail relative to the products available to treat this condition.
Provides definition and market structure, including discussion on cognition and diagnostic tests
Analyzes market size and key players
Identifies worldwide industry structure, including growth drivers and obstacles, and related technology considerations
Details primary and secondary applications, legislation and the regulatory environment, related deals, and partnerships, patent analysis, and company profiles.
Analyzes the market outlook, trends, and challenges.
Source: http://www.reportlinker.com
f53564ae-fb08-4d58-837e-7388e4967c87|0|.0
Posted in: Medical Condition News
Tags: Alzheimer's Disease, Biotechnology, Brain, Calcium, Cannabinoid, Cortex, Dementia, Dopamine, Gene Therapy, Histamine, Huntington's Disease, Multiple Sclerosis, Parkinson's Disease, Pfizer, Psychotherapy, Schizophrenia, Serotonin